Kininogène poids moléculaire élevé, deux chaînes de plasma humain, poudre lyophilisée

Code: k1632-.1mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

High molecular weight kininogen, two chain, is a participant in contact phase activation of the intrinsic blood coagulation cascade that forms a subst...


en savoir plus

Votre prix
$129.20 EACH

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

High molecular weight kininogen, two chain, is a participant in contact phase activation of the intrinsic blood coagulation cascade that forms a substrate on which blood factor XI is held in proximity to factor XII allowing reciprocal activation of the two factors. It is also involved in the activation of prekallikrein. High molecular weight kininogen binds to proteoglycans on the surface of platelets, endothelial cells, and other cell types. Domain 5 of high molecular weight kininogen inhibits platelet aggregation and angiogenesis.

High-molecular-weight kininogen (HK) inhibits binding of thrombin to platelets.

General description

HK (KNG1) gene is mapped to human chromosome 3q27.3. It is a glycoprotein.

High-molecular-weight kininogen (HK) is the substrate and cofactor of the plasma kallikrein-kinin system (KKS). It is present at a concentration of 660 nM on the plasma and binds to platelet GPI-V-IX complex.

Packaging

Package size based on protein content

Physical form

Lyophilized from 4 mM sodium acetate, pH 5.3, 0.15 M NaCl

Preparation Note

Prepared by kallikrein digestion of human kininogen. Purified to remove kallikrein and kinin.

biological sourcehuman plasma
formlyophilized powder
Gene Informationhuman ... KNG1(3827), KNG1 (includes EG:3827)(3827)
Quality Level200
solubilityH2O: soluble 0.1 mg protein/mL
storage temp.−20°C
UniProt accession no.P01042
Ce produit répond aux critères suivants: